Synthomer agrees sale of Czech acrylate monomers business.

Synthomer announced on Friday that it has agreed to sell its Czech acrylate monomers business to Mutares, as the chemicals group continues to simplify its portfolio and focus on higher-margin speciality markets.

Synthomer
19 June 2026 15:06:01

Source: Sharecast

The business, based in Sokolov and employing about 300 people, supplies acrylic acid and related monomers to the European merchant market and supports some of Synthomer’s downstream operations.

Synthomer said existing supply arrangements with the group would continue under Mutares’ ownership.

Acrylate Monomers generated external sales of €68m in 2025 and recorded a standalone adjusted EBITDA loss of €10m, although trading improved to break-even in the first four months of 2026.

The deal is expected to complete at the end of the third quarter, with consideration structured as a cash generation sharing arrangement of up to €12m over three years and no initial payment at closing.

At 1157 BST, shares in Synthomer were down 0.72% at 110p.

Reporting by Josh White for Sharecast.com.

See latest RNS on Investegate

N/A

ISIN: N/A

Exchange: N/A

Sell:

N/A

Buy:

N/A

Change:

Date:

Prices delayed by at least 15 minutes

Compare our accounts

If you're looking to grow your money over the longer term (5+ years), we have a range of investment choices to help.

View our accounts

Halifax is not responsible for the content and accuracy of the Markets News articles. We may not share the views of the author. Understand the risks, please remember the value of your investment can go down as well as up and you may not get back the full amount you invest. We don't provide advice so if you are in any doubt about buying and selling shares or making your own investment decisions we recommend you seek advice from a suitably qualified Financial Advisor. Past performance is not a guide to future performance.